Hutex Famotidine Tablet 20mg

Adult dose

1. For gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal hemorrhage, gastroesophageal reflux disease, and Zollinger-Ellison syndrome: Take 20 mg orally, twice a day (after breakfast, after dinner, or at bedtime) or take 40 mg once a day (at bedtime). In cases of upper gastrointestinal hemorrhage, start treatment with an injection and then switch to oral administration when possible. 2. For improving gastric mucosal lesions during the exacerbation of acute gastritis or chronic gastritis: Take 10 mg orally, twice a day (after breakfast, after dinner, or at bedtime) or take 20 mg once a day (at bedtime).

This medication should not be used in patients who are allergic to specific ingredients or have a genetic lactose metabolism disorder. Patients with a history of drug allergies, renal, hepatic, or cardiac diseases, and the elderly should exercise special caution when using this medication. Though rare, this medication can cause serious allergic reactions, blood abnormalities, skin disorders, liver function impairment, muscle problems, cardiac rhythm disturbances, neurological disorders, kidney damage, and pulmonary diseases, among other serious side effects, so if any abnormal symptoms occur during use, medical personnel should be consulted immediately. Generally, it is recommended to use the minimum necessary dosage while closely monitoring the treatment course, and if no effect is seen, switching to other treatments is advisable. This medication should be swallowed with saliva or water, as it dissolves in the mouth but is not absorbed through the oral mucosa. Patients undergoing hemodialysis should be cautious as the effectiveness of this medication may decrease when combined with certain phosphate binders. Interactions with other medications may occur, so special caution is needed, especially when taking antifungal or certain anticancer drugs. The elderly often have diminished renal function, which may increase the drug concentration, so dosage adjustments may be necessary. Women who are pregnant or may become pregnant should only use this medication when the benefits outweigh the risks, and nursing mothers are advised to discontinue breastfeeding during use. Safety in children has not been sufficiently confirmed, so caution should be exercised in their use. In particular, for the orally disintegrating tablet form, it should be placed on the tongue and allowed to dissolve in saliva before swallowing, and should not be taken while lying down without water. This medication may mask symptoms of stomach cancer, so it should only be used after confirming malignancy.

Serious side effects

Shock, anaphylaxis, respiratory distress, general flushing, vascular swelling (facial swelling, pharyngeal edema), hives, pancytopenia, agranulocytosis, aplastic anemia, hemolytic anemia, thrombocytopenia, Stevens-Johnson syndrome, Lyell syndrome, liver function impairment, jaundice, rhabdomyolysis, QT prolongation, ventricular tachycardia, ventricular fibrillation, consciousness disturbances, generalized seizures (tonic, clonic, myoclonic), interstitial nephritis, acute renal failure, interstitial pneumonia, contraction failure

Mild side effects

• Rash
• pruritus
• hives (erythema)
• facial swelling
• constipation
• diarrhea
• soft stools
• dry mouth
• nausea
• vomiting

This medication should be stored in a tightly sealed container to protect it from air, with a safe storage temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the effectiveness of the medication for a long time.

Appearance

Light green, round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle, 1000 tablets/bottle